ABSTRACT
Endometrial cancer is now the most frequent gynaecologic cancer in developed countries, whereas c ervical cancer is the most frequent in the developing world. Imaging plays a central role in the evaluation of extent of disease both at the time of presentation and in suspected recurrent disease. Imaging informs treatment planning decisions throughout the patient pathway, including the choice of surgery or chemoradiotherapy, fertility preservation, extent of radiotherapy field, and planning of salvage treatment for recurrent disease. Ultrasound (US), magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET)-CT are indicated in different clinical scenarios, in view of their strengths and weaknesses.
